- Home
- CATX vs AGL Comparison
CATX vs AGL Comparison
Compare CATX & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- AGL
- Stock Information
- Founded
- CATX 1983
- AGL 2016
- Country
- CATX United States
- AGL United States
- Employees
- CATX N/A
- AGL N/A
- Industry
- CATX Medical/Dental Instruments
- AGL Managed Health Care
- Sector
- CATX Health Care
- AGL Health Care
- Exchange
- CATX Nasdaq
- AGL Nasdaq
- Market Cap
- CATX 239.0M
- AGL 276.6M
- IPO Year
- CATX N/A
- AGL 2021
- Fundamental
- Price
- CATX $2.08
- AGL $0.64
- Analyst Decision
- CATX Strong Buy
- AGL Hold
- Analyst Count
- CATX 11
- AGL 17
- Target Price
- CATX $11.73
- AGL $2.79
- AVG Volume (30 Days)
- CATX 2.0M
- AGL 12.8M
- Earning Date
- CATX 11-10-2025
- AGL 11-04-2025
- Dividend Yield
- CATX N/A
- AGL N/A
- EPS Growth
- CATX N/A
- AGL N/A
- EPS
- CATX N/A
- AGL N/A
- Revenue
- CATX $1,075,000.00
- AGL $5,885,571,000.00
- Revenue This Year
- CATX N/A
- AGL N/A
- Revenue Next Year
- CATX N/A
- AGL $5.76
- P/E Ratio
- CATX N/A
- AGL N/A
- Revenue Growth
- CATX N/A
- AGL 5.21
- 52 Week Low
- CATX $1.60
- AGL $0.51
- 52 Week High
- CATX $5.39
- AGL $6.08
- Technical
- Relative Strength Index (RSI)
- CATX 32.16
- AGL 38.45
- Support Level
- CATX $2.00
- AGL $0.51
- Resistance Level
- CATX $2.54
- AGL $0.86
- Average True Range (ATR)
- CATX 0.20
- AGL 0.07
- MACD
- CATX 0.02
- AGL 0.00
- Stochastic Oscillator
- CATX 19.51
- AGL 33.50
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.